Alto Neuroscience, Inc. (ANRO)

USD 3.64

(-3.96%)

Revenue Summary of Alto Neuroscience, Inc.

  • Alto Neuroscience, Inc.'s latest annual revenue in 2023 was - USD , down 0.0% from previous year.
  • Alto Neuroscience, Inc.'s latest quarterly revenue in 2024 Q1 was - USD , down -100.0% from previous quarter.
  • Alto Neuroscience, Inc. reported a annual revenue of - USD in annual revenue 2022, down -100.0% from previous year.
  • Alto Neuroscience, Inc. reported a annual revenue of 210 Thousand USD in annual revenue 2021, down 0.0% from previous year.
  • Alto Neuroscience, Inc. reported a quarterly revenue of - USD for 2024 Q2, down 0.0% from previous quarter.
  • Alto Neuroscience, Inc. reported a quarterly revenue of - USD for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Alto Neuroscience, Inc. (2023 - 2021)

Historical Annual Revenue of Alto Neuroscience, Inc. (2023 - 2021)

Year Revenue Revenue Growth
2023 - USD 0.0%
2022 - USD -100.0%
2021 210 Thousand USD 0.0%

Peer Revenue Comparison of Alto Neuroscience, Inc.

Name Revenue Revenue Difference
ADC Therapeutics SA 69.55 Million USD 100.0%
Annovis Bio, Inc. - USD NaN%
Biohaven Pharmaceutical Holding Company Ltd. - USD NaN%
Ginkgo Bioworks Holdings, Inc. 251.45 Million USD 100.0%
Nuvation Bio Inc. - USD NaN%
Nuvation Bio Inc. - USD NaN%
Arcus Biosciences, Inc. 117 Million USD 100.0%
Theriva Biologics, Inc. - USD NaN%
Zymeworks Inc. 76.01 Million USD 100.0%